Swoop

We’re proud to share that Swoop’s Corporate Counsel team has been recognized as a 2026 Top 50 Corporate Counsel Team by OnConferences! Their impact goes far beyond legal guidance. Through trusted partnership and thoughtful leadership, they safeguard our work, enable innovation, and drive Swoop forward every single day. Congratulations to our entire legal team on this well-deserved recognition!

How will agentic AI transform the future of commercial operations in pharma? Swoop is excited to sponsor the Agentic Pharma Summit in Philadelphia. As AI capabilities advance, commercial leaders must lead with future-proof strategies — using these tools to empower teams, accelerate therapy adoption, and elevate patient outcomes. Will you be in Philadelphia? Let's connect to keep the conversation going.

Swoop is honored to be named a 2026 PMEA finalist for Excellence in Engagement through Digital Channels and New Technology! Our Patient Voice Forward campaign combined authentic rare disease perspectives with digital education to turn industry awareness into real impact. Real patient experiences build better digital engagement. This recognition reinforces a simple idea: digital engagement is most effective when it begins with real patient experience.

What if message testing was an ongoing conversation instead of a one-time checkpoint? At the Agentic Pharma Summit, Swoop VP of Product Romain Bogaerts will explore how simulated patient perspectives help pharma teams challenge assumptions, uncover authentic motivations, and craft more relevant messaging. This session demonstrates how pairing agentic AI with privacy-safe, real-world insights elevates creative resonance and accelerates the treatment journey, while keeping human judgment and lived experience at the center of every decision.

Thank you to Customer Magazine (TMC) and CustomerZone360 for recognizing Swoop Web Solutions with the Conversational AI Excellence Award! Swoop Web Solutions help brand managers and healthcare agencies elevate website UX by answering visitor questions, streamlining site navigation, and uncovering zero- and first-party engagement insights. Thank you to Customer magazine (TMC) and CustomerZone360 for recognizing our commitment to driving innovation in customer experience. Learn More: https://lnkd.in/ew5FmamA

When patients experience narcolepsy across the full day, treatment priorities must go beyond daytime symptom relief. Our most recent patient-first research from Swoop Communities and Alkermes reveals that 85 percent of respondents want treatments that improve sleep quality. Nighttime symptoms matter. To deliver truly patient-first care, healthcare brands must understand and address the full 24-hour cycle of this condition. Learn More: https://lnkd.in/e99-ex4n

What happens after an HCP or patient engages with your brand? Awareness is only step one. The real challenge — and opportunity — is supporting the rest of the journey toward diagnosis, treatment, and adherence. Swoop connects the touchpoints across the commercial lifecycle so brands can turn engagement into meaningful health outcomes. Learn More: https://lnkd.in/gcAbqXQU

TV in healthcare is evolving beyond brand awareness. In conversation with Beet.TV, OpenAP Chief Revenue Officer Ashley M. L. explains how data, identity, and measurement connect audiences and HCPs to condition-specific care — showing whether awareness leads to real-world outcomes. Used intentionally, responsibly, and with accountability, pharma advertising can do more than drive commercial performance. It can help change lives for the better. Learn More: https://lnkd.in/emNza4Rf

What do IBD patients need most when considering advanced treatment options? According to new MyCrohnsAndColitisTeam research, the answer starts with education, trust, and clear conversations with the right specialist. The survey found that 88% of Crohn’s disease and ulcerative colitis respondents say IBD has negatively impacted their quality of life. Among patients who have never taken an advanced immunotherapy, awareness remains limited, and concerns about side effects or safety are the leading barrier. These insights reinforce the need for patient-first education that helps people with IBD weigh concerns, understand potential benefits, and engage in more informed conversations with gastroenterologists. Learn More: https://lnkd.in/gcmQZ2Vm

As state privacy laws continue to evolve, staying ahead requires seamless collaboration across legal, data, media, and marketing teams. On November 18, Swoop’s Ben Chapman and Rebecca Joseph, CIPP/US will be attending the IAB State Privacy Law Summit in New York to explore the latest regulatory developments, enforcement trends, and practical approaches to streamline privacy across digital advertising. Attending the summit? Connect with Ben and Rebecca to exchange perspectives on building privacy-safe strategies for what’s ahead.